# US 2022/0023491 A1 · Hemostatic Composite Aggregate Materials Having Surface Enriched with Hemostatis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0023491 A1
- Document ID: US20220023491A1
- Status: Published application
- Kind: A1
- Application number: 16/934,998
- Filed: 2020-07-21
- Published: 2022-01-27
- Earliest claimed: 2020-07-21
- Assignees: Ethicon, Inc.
- Applicants: Ethicon, Inc.
- Inventors: Yi-Lan Allen Wang; Jerry Yan; Leo B. Kriksunov
- Web page: https://patentgrep.com/patent/US20220023491A1

## CPC

- A61L 24/0042: {Materials resorbable by the body}
- A61L 26/0066: {Medicaments; Biocides}
- A61L 24/001: {Use of materials characterised by their function or physical properties}
- A61L 24/08: Polysaccharides {(A61L24/043 takes precedence)}
- A61L 24/102: {Collagen}
- A61L 24/104: {Gelatin}
- A61L 26/0038: {Gelatin}
- A61L 2400/04: Materials for stopping bleeding
- A61L 2420/02: Methods for coating medical devices
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

The present invention relates to a hemostatic absorbable composition, comprising: a flowable plurality of separate aggregates each comprising: a plurality of absorbable carrier particles coated on a surface thereof by a plurality of smaller particles comprising an absorbable supplemental hemostasis-promoting agent. In some embodiments, the absorbable carrier particles comprise gelatin or collagen, and the supplemental hemostasis-promoting agent comprises oxidized cellulose, oxidized regenerated cellulose, carboxylic oxidized cellulose, carboxylic oxidized regenerated cellulose, thrombin, or tranexamic acid.

## Claims

### Claim 1

A hemostatic absorbable composition, comprising:
a flowable plurality of separate aggregates each aggregate being an absorbable carrier particle having a first size dimension that is coated on a surface thereof by a plurality of hemostasis-promoting particles having a size dimension smaller than the first size dimension.

### Claim 2 (depends on 1)

The hemostatic absorbable composition of claim 1, wherein the supplemental hemostasis promoting agent is present exclusively or primarily on an outside surface of the carrier particles or in an outside layer of the carrier particles.

### Claim 3 (depends on 1)

The hemostatic absorbable composition of claim 1, wherein an internal portion of the carrier particles contains substantially none of said supplemental hemostasis-promoting agent.

### Claim 4 (depends on 1)

The hemostatic absorbable composition of claim 1, wherein the separate aggregates have average dimensions between 100 and 500 microns.

### Claim 5 (depends on 1)

The hemostatic absorbable composition of claim 1, wherein the absorbable carrier particles comprise gelatin or collagen.

### Claim 6 (depends on 1)

The hemostatic absorbable composition of claim 1, wherein the absorbable carrier particles comprise thermally cross-linked gelatin.

### Claim 7 (depends on 1)

The hemostatic absorbable composition of claim 1, wherein the supplemental hemostasis-promoting agent comprises carboxylic oxidized cellulose, carboxylic oxidized regenerated cellulose, thrombin, or tranexamic acid.

### Claim 8 (depends on 1)

The hemostatic absorbable composition of claim 1, wherein the supplemental hemostasis-promoting agent comprises oxidized regenerated cellulose in a form of a fine elongated particles having aspect ratio on average of at least 3 or higher.

### Claim 9 (depends on 1)

The hemostatic absorbable composition of claim 1, wherein the absorbable carrier particles comprise particles having an aspect ratio on average of lower than 3.

### Claim 10 (depends on 1)

The hemostatic absorbable composition of claim 1, wherein the supplemental hemostasis-promoting agent comprises oxidized regenerated cellulose and the absorbable carrier particles comprise gelatin, wherein a mass ratio of ORC:gelatin is greater than 10:1.

### Claim 11 (depends on 10)

The hemostatic absorbable composition of claim 10, wherein the mass ratio of ORC:gelatin is greater than 17:1.

### Claim 12 (depends on 11)

The hemostatic absorbable composition of claim 11, wherein the mass ratio of ORC:gelatin is from about 17:1 to 30:1.

### Claim 13 (depends on 1)

A method of making the hemostatic absorbable composition of claim 1, comprising the steps of:
a) hydrating the absorbable carrier particles;
b) mixing the hydrated absorbable carrier particles with the smaller particles comprising the absorbable supplemental hemostasis-promoting agent;
c) forming a mixture with the smaller particles comprising the absorbable supplemental hemostasis-promoting agent adhering to the absorbable carrier particles;
d) drying the mixture; and optionally
e) sieving the mixture.

### Claim 14 (depends on 13)

The method of claim 13, wherein the step of mixing comprises shaking the mixture in a container or ball milling the mixture.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

A method of treating a wound, comprising applying the hemostatic absorbable composition of any one of claims 1 to 12 onto or into the wound.
